Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the bioreactors market right now?

The market for bioreactors has experienced swift expansion in the recent past. Projected growth indicates an increase from $9.22 billion in 2024 to $10.64 billion in 2025, a compound annual growth rate (CAGR) of 15.2%. Factors contributing to this historic period of growth include an amplified demand for biopharmaceuticals, an increase in cell and gene therapy research, a greater emphasis on personalized medicine, the adoption of single-use bioreactor technology, and the need for more effective manufacturing processes.

How fast Is the bioreactors market expected to grow, and what’s its future value?

The bioreactors market is predicted to experience a fast-paced growth in the upcoming years, escalating to a substantial $18.58 billion by 2029 with a compound annual growth rate (CAGR) of 14.9%. The foreseen growth in this period can be credited to the escalating investment in biotechnology research, increased occurrence of chronic diseases, burgeoning demand for vaccines and therapeutic proteins, an upsurge in regulatory assistance for biomaking, and rising application of advanced therapies. The impending trends in this period comprise progress in biotechnology, enhancements in automation and control systems, increased focus on bioprocess development, improvement in manufacturing efficiency, and a growing requirement for scalable production solutions.

Get your bioreactors market report here!

https://www.thebusinessresearchcompany.com/report/bioreactors-global-market-report

What are the leading drivers of growth in the bioreactors market?

The surge in biopharmaceuticals demand is predicted to stimulate expansion in the bioreactors market. Biopharmaceuticals are medicines produced from biological elements like proteins, cells, and living organisms, utilized for the prevention, management, or treatment of various diseases. The rising demand for biopharmaceuticals springs from the progress in medical research, bespoke medicine, and an impetus for novel treatments, all of which contribute to enhanced global healthcare outcomes. Bioreactors offer invaluable assistance for biopharmaceuticals, as they facilitate effective and scalable manufacturing of therapeutic products, assure consistent quality, cut production expenses, and enable the creation of innovative and life-improving medicines. For example, the Pharmaceutical Research and Manufacturers of America, a trade organization based in the US, reported in May 2024 that the US biopharmaceutical sector surpassed $1.65 trillion in total yield in 2022, with $800 billion coming directly from production and an extra $800 billion from suppliers and other sectors, contributing to 3.6% of the US economy. Hence, the upsurge in demand for biopharmaceuticals is fuelling the growth of the bioreactors market.

What are the key segments defining the bioreactors market?

The bioreactors market covered in this report is segmented –

1) By Type Of Bioprocess: Batch And Fed-Batch, Continuous

2) By Cell: Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells

3) By Control: Manual, Automated

4) By Usage: Lab Scale Production, Pilot Scale Production, Full Scale Production

5) By End-Use: Research And Development (R&D) Organizations, Biopharmaceutical (Biopharma) Manufacturers, Contract Manufacturing Organizations (CMOS)

Subsegments:

1) By Batch And Fed-Batch: Traditional Batch Bioreactors, Fed-Batch Bioreactors

2) By Continuous: Perfusion Bioreactors, Continuous Stirred Tank Bioreactors (CSTR)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20721&type=smp

Who are the key players steering the development of the bioreactors market?

Major companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, Broadley-James Corporation, PBS Biotech Inc., TAP Biosystems, Solida Biotech GmBH, BBI-Biotech GmbH, HiTec Zang GmbH, Xiamen Ollital Technology Co. Ltd., Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, Shanghai Ritai Medicine Equipment Project Co. Ltd.

What emerging trends are influencing the growth of the bioreactors market?

Major companies operating in the bioreactors market are focusing on developing advanced products such as fixed-bed bioreactors to support the growth of more complex biological cultures. A fixed-bed bioreactor is a type of bioreactor in which biological organisms are attached to a solid support, typically composed of porous materials such as beads, fibers, or granules. This design enhances mass transfer, minimizes shear stress, and provides better control over the biological processes. For instance, in October 2024, Univercells Technologies, a Belgium-based biotechnology company, launched the Scale-X Nexo bioreactor. This cutting-edge bioreactor, featuring a 0.5 m² growth surface, is specifically designed to optimize cell culture process development, offering significant benefits for biopharmaceutical companies and research institutions. The scale-X nexo facilitates seamless scalability to larger models, reduces media and reagent consumption, and can lower operational costs by up to 60% compared to traditional entry-level bioreactors. Additionally, it integrates with the Skaia Vision application software, further boosting productivity by providing precise cell count estimations without the need for direct sampling.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20721

Which regions are most influential in expanding the bioreactors market?

North America was the largest region in the bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Small-Scale Bioreactors Global Market Report 2025

https://thebusinessresearchcompany.com/report/small-scale-bioreactors-global-market-report

Feed Yeast Global Market Report 2025

https://thebusinessresearchcompany.com/report/feed-yeast-global-market-report

Bioethanol Yeast Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/bioethanol-yeast-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: